Start Date: | 12/16/2024 | Start Time: | 10:00 AM |
End Date: | 12/16/2024 | End Time: | 12:00 PM |
|
Event Description BIOMED PhD Thesis Defense
Title:
Multiomics-based (MOB) Approach to Understanding Genomic and Functional Features Shared by Osteosarcoma and Bone Metastatic Prostate (BMP) Cancer
Speaker:
Waleed Iqbal, PhD Candidate
School of Biomedical Engineering, Science and Health Systems
Drexel University
Advisor:
Alessandro Fatatis, MD, PhD
Professor of Pharmacology, Physiology and Pathology
College of Medicine
Drexel University
Details:
This research identifies key molecular and epigenetic drivers of tumor cells’ survival and growth in the skeleton by investigating bone-metastatic prostate cancer and primary osteosarcoma, through the integration of gene expression and methylation data using statistical and machine learning approaches. Aim 1 focused on developing methodologies for analyzing methylation and gene expression data, including the design and analysis of the novel mm285 mouse methylation array. These approaches were applied in Aim 2 to bone-tropic prostate cancer, verifying the inverse relationship between the androgen receptor and the cytokine Interleukin-1beta and identifying differential methylation as a regulatory mechanism.
Additional analyses highlighted the role of the chemokine receptor CX3CR1 and also compared bone-metastatic prostate adenocarcinoma to neuroendocrine prostate cancer that metastasized to soft tissues. In Aim 3, a random forest model identified 140 genes differentiating bone metastatic from non-bone metastatic prostate cancers, with 88 showing consistent trends in primary osteosarcoma and 8 linked to significantly worse patients’ survival. Methylation data revealed 85 CpGs correlated with these genes, including 54 CpGs with positive and 31 with negative correlations, implicating enhancer-mediated activation and methylation-induced repression. These findings highlight critical regulatory elements and provide a foundation for experimental validation of the newly acquired information with the ultimate goal of identifying novel therapeutic targets for the treatment of both primary and secondary bone tumors. |
|
Audience: Undergraduate StudentsGraduate StudentsFacultyStaff |
|